13F Pro quality score
Rank #2,840 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from BIOMERICA INC's annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2026 | 10-K | $4.5M | $-3.8M | -119.5% |
| FY 2025 | 10-K | $5.3M | $-5.0M | -96.7% |
| FY 2024 | 10-K | $5.4M | $-6.0M | -117.6% |
| FY 2023 | 10-K | $5.3M | $-7.1M | -135.3% |
| FY 2022 | 10-K | $18.9M | $-4.5M | -24.0% |
| FY 2021 | 10-K/A | $7.2M | $-7.4M | -104.2% |
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
BIOMERICA INC (BMRA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BMRA at 13.1/100 on a composite quality score built from its SEC filings, placing it at rank #2,840 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q1 2027), BIOMERICA INC reports quarterly revenue of $1.3M, net income of $-1.2M, an operating margin of -97.0%. Top institutional holders of BMRA by reported 13-F value include HRT FINANCIAL, GEODE CAPITAL MANAGEMENT, BlackRock, based on the most recent SEC filings. BMRA trades on the Nasdaq exchange and files with the SEC under CIK 73290. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BMRA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BIOMERICA INC directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 73290 →